4.6 Review

Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Rajiv Agarwal et al.

Summary: The study found that finerenone can reduce the risk of kidney disease and cardiovascular events in patients with type 2 diabetes. Screening patients for albuminuria can help reduce the burden of cardiovascular and kidney disease.

EUROPEAN HEART JOURNAL (2022)

Review Peripheral Vascular Disease

Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?

Indranil Dasgupta et al.

Summary: Meticulous management of hypertension is crucial for reducing the risk of cardiovascular disease, mortality, and progression of CKD in patients with chronic kidney disease. However, the recently published KDIGO guideline's recommendation of a systolic blood pressure target of <120 mm Hg is controversial and not applicable to the majority of CKD patients.

HYPERTENSION (2022)

Review Biochemistry & Molecular Biology

The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation

Leandro Moretti et al.

Summary: This article discusses the impact of fibrosis on global mortality and explores the differences between scarless wound healing in fetuses and adults. The interplay between the extracellular matrix, fibroblasts, and inflammatory mediators is highlighted, and new research directions are proposed to better understand and address fibroproliferative diseases.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Review Urology & Nephrology

Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD

Nicole M. Lioufas et al.

Summary: Noncalcium-based phosphate-lowering therapy can reduce serum phosphate and urinary phosphate excretion in CKD patients. However, its effects on clinical outcomes and intermediate cardiovascular endpoints are unclear.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Urology & Nephrology

Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure

Debbie C. Chen et al.

Summary: The differential between eGFR(cys) and eGFR(cr) is associated with the risk of heart failure among patients with chronic kidney disease. Diverging slopes over time between eGFR(cys) and eGFR(cr) are also independently associated with the risk of heart failure.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Article Hematology

Runx2 (Runt-Related Transcription Factor 2) Links the DNA Damage Response to Osteogenic Reprogramming and Apoptosis of Vascular Smooth Muscle Cells

Andrew M. Cobb et al.

Summary: The study found that DNA damage stimulates Runx2 accumulation and enhances its activation of osteogenic target genes, leading to increased calcification. Runx2 also participates in DNA repair and its PARylation in response to genotoxic stress affects its localization at DNA lesions.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Urology & Nephrology

Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study

Edouard L. Fu et al.

Summary: The study found that stopping RAS inhibitor therapy in patients with advanced CKD was associated with higher risks of mortality and major adverse cardiovascular events, but lower risk of initiating kidney replacement therapy (KRT).

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Review Urology & Nephrology

Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence

Radica Z. Alicic et al.

Summary: Incretin-based therapies, such as GLP1R agonists and DPP4 inhibitors, have shown protective effects in diabetic kidney disease patients, with potential mechanisms including immunomodulation and anti-inflammatory actions. These drugs not only lower blood glucose levels effectively but also reduce the risk of developing chronic kidney disease and cardiovascular events, in addition to potentially attenuating oxidative stress and cellular apoptosis in the kidney.

NATURE REVIEWS NEPHROLOGY (2021)

Article Transplantation

Tissue sodium stores in peritoneal dialysis and hemodialysis patients determined by sodium-23 magnetic resonance imaging

Melis Sahinoz et al.

Summary: The study revealed that dialysis patients have higher muscle and skin Na+ accumulation compared to controls. Different ethnicities among dialysis patients may have varying levels of muscle and skin Na+. Systemic inflammation is correlated with increased muscle and skin Na+ content in dialysis patients.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Review Cell Biology

A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors

Taha Sen et al.

Summary: SGLT2 inhibitors reduce the risk of kidney failure in patients with and without type 2 diabetes by mechanisms including reductions in intraglomerular pressure, blood pressure reduction, decreased tubular workload, and increased autophagy. These mechanisms may also explain the beneficial effects of SGLT2 inhibitors on kidney function in patients without type 2 diabetes.

CELL METABOLISM (2021)

Article Medicine, General & Internal

Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease

Rajiv Agarwal et al.

Summary: In patients with CKD and poorly controlled hypertension, chlorthalidone therapy improved blood pressure control at 12 weeks compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Urology & Nephrology

Two-Week Burden of Arrhythmias across CKD Severity in a Large Community-Based Cohort: The ARIC Study

Esther D. Kim et al.

Summary: The study found a higher prevalence of atrial fibrillation and nonsustained ventricular tachycardia among older adults with more severe CKD. Albuminuria was associated with a higher prevalence of atrial fibrillation and nonsustained ventricular tachycardia, while eGFR was associated with the frequency of atrioventricular block.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Urology & Nephrology

Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Alfred K. Cheung et al.

Summary: The updated KDIGO guideline on blood pressure management in chronic kidney disease emphasizes the importance of evidence-based recommendations, with a focus on blood pressure targets, antihypertensive medications, and specific management for kidney transplant recipients. The guideline also highlights the significance of proper blood pressure measurement protocols.

KIDNEY INTERNATIONAL (2021)

Review Urology & Nephrology

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

Ralph A. DeFronzo et al.

Summary: Diabetic kidney disease is a leading cause of kidney failure globally, with over 50% of individuals entering dialysis or transplant programmes in the USA affected by it. Hyperglycaemia is the primary factor in its development, leading to various pathophysiological disturbances that contribute to progressive glomerular sclerosis and declining renal function. Multiple agents used in combination are likely to be needed to effectively slow the progression of the disease.

NATURE REVIEWS NEPHROLOGY (2021)

Article Nutrition & Dietetics

Impact of Obesity in Kidney Diseases

Vasilios Kotsis et al.

Summary: Obesity is closely related to renal damage, and weight reduction is key in limiting the impact on kidneys, reducing albuminuria/proteinuria, slowing down the decline in renal function, delaying the development of CKD, and improving outcomes of renal transplantation.

NUTRIENTS (2021)

Editorial Material Urology & Nephrology

The need for a cardionephrology subspecialty

Javier Diez et al.

Summary: CKD patients frequently suffer from cardiovascular complications, resulting in significant clinical, public health, and economic burdens. Enhanced training in cardionephrology is necessary to improve clinical management and outcomes for this patient population.

CLINICAL KIDNEY JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Cardiovascular Disease in Chronic Kidney Disease Pathophysiological Insights and Therapeutic Options

Joachim Jankowski et al.

Summary: Patients with chronic kidney disease face an increased risk of cardiovascular events, with advanced CKD stages significantly elevating the risk. Cardiovascular events, rather than end-stage kidney disease, are the leading cause of death in this high-risk population, and CKD causes a proinflammatory state that affects the cardiovascular system.

CIRCULATION (2021)

Review Endocrinology & Metabolism

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Naveed Sattar et al.

Summary: The meta-analysis showed that GLP-1 receptor agonists can reduce the risk of major adverse cardiovascular events, all-cause mortality, hospital admission for heart failure, and worsening kidney function in patients with type 2 diabetes, regardless of structural homology.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Review Biochemistry & Molecular Biology

Kidney disease and APOL1

Aminu Abba Yusuf et al.

HUMAN MOLECULAR GENETICS (2021)

Review Cell Biology

ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress

Joseph Adu-Amankwaah et al.

Summary: Heart failure development is characterized by chronic catecholamine stress leading to persistent inflammation and progressive fibrosis. ADAM17 plays a key role in regulating inflammation and fibrosis by cleaving and activating proinflammatory cytokines and fibrotic factors. The activation and regulation of ADAM17 during chronic catecholamine stress in heart failure as well as its substrates and their impact on cardiac dysfunction are important areas for further research.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease-Mineral and Bone Disorder

Maria L. Mace et al.

Summary: The vasculature plays a key role in bone development and tissue maintenance, and is linked to bone disorders in both normal and pathophysiological conditions. CKD-MBD is a serious complication of CKD, with current treatment strategies not effectively reducing cardiovascular mortality in patients. Research indicates a direct effect of vascular calcification on bone metabolism in CKD, suggesting a potential new target for treatment and prevention.

METABOLITES (2021)

Article Medicine, General & Internal

Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD

Glenn M. Chertow et al.

Summary: Vadadustat, compared to darbepoetin alfa, met the prespecified noninferiority criterion for hematologic efficacy but not for cardiovascular safety in patients with NDD-CKD.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

Kai-Uwe Eckardt et al.

Summary: Vadadustat, an oral prolyl hydroxylase inhibitor, was found to be noninferior to darbepoetin alfa in terms of cardiovascular safety and hemoglobin concentration in anemia patients with CKD undergoing dialysis, based on two phase 3 trials.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Medicine, General & Internal

Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents

Jose Portoles et al.

Summary: Anemia is a common complication in chronic kidney disease (CKD) and is managed with iron supplements and erythropoiesis stimulating agents. Advances in treatment, such as the development of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) and insights from recent clinical trials on iron supplementation, may change future treatment targets.

FRONTIERS IN MEDICINE (2021)

Article Medicine, General & Internal

Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US

Lauren A. Eberly et al.

Summary: This study showed that Black and female patients as well as those with low socioeconomic status were less likely to receive SGLT2 inhibitor treatment among patients with type 2 diabetes in the US.

JAMA NETWORK OPEN (2021)

Article Cardiac & Cardiovascular Systems

Uremic Toxins and Cardiovascular System

Sophie Valkenburg et al.

CARDIOLOGY CLINICS (2021)

Article Endocrinology & Metabolism

Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 US Health Care Organizations

Nikita Stempniewicz et al.

Summary: The study found that eGFR testing rates are generally high among people with type 2 diabetes in the U.S., but testing rates for uACR are suboptimal and vary significantly across different organizations and clinical practice sites. Increasing guideline-recommended uACR testing could enhance the detection of chronic kidney disease (CKD) in this population.

DIABETES CARE (2021)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Letter Cardiac & Cardiovascular Systems

Albuminuria and Prognosis Among Individuals With Atherosclerotic Cardiovascular Disease The ARIC Study

Yejin Mok et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Urology & Nephrology

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

Cynthia Delgado et al.

Summary: A Task Force developed recommendations for reassessing inclusion of race in GFR estimation in the United States. The recommendations include immediate implementation of a creatinine equation refit without the race variable and increasing the use of cystatin C, as well as encouraging research on new filtration markers and interventions to eliminate racial and ethnic disparities.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Medicine, General & Internal

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Bin Zhou et al.

Summary: Global prevalence of hypertension doubled from 1990 to 2019, with significant improvements in detection, treatment, and control rates. In 2019, 59% of women and 49% of men with hypertension were previously diagnosed, while treatment rates were 47% for women and 38% for men, with control rates at 23% for women and 18% for men. Disparities exist across countries, with some middle-income nations now outperforming high-income countries in hypertension management.

LANCET (2021)

Article Medicine, General & Internal

Effect of Salt Substitution on Cardiovascular Events and Death

B. Neal et al.

Summary: The study found that among individuals with a history of stroke or aged 60 or older with high blood pressure, using a salt substitute can reduce the rates of stroke, major cardiovascular events, and death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Duration of Diabetes and Incident Heart Failure The ARIC (Atherosclerosis Risk In Communities) Study

Justin B. Echouffo-Tcheugui et al.

Summary: This study found that longer duration of diabetes is associated with an increased risk of incident heart failure. The association was stronger among younger individuals, those with poorer glycemic control, higher body mass index, women, and Blacks. The study suggests that delaying diabetes onset may help prevent heart failure, and interventions targeting individuals with long-standing diabetes may improve heart failure outcomes.

JACC-HEART FAILURE (2021)

Article Urology & Nephrology

Measured and estimated glomerular filtration rate: current status and future directions

Andrew S. Levey et al.

NATURE REVIEWS NEPHROLOGY (2020)

Article Urology & Nephrology

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD

Julio Alejandro Lamprea-Montealegre et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Cardiac & Cardiovascular Systems

Management and outcomes of heart failure patients with CKD: experience from an inter-disciplinary clinic

Mai Nguyen et al.

ESC HEART FAILURE (2020)

Article Urology & Nephrology

Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure

Gregory A. Nichols et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Medicine, General & Internal

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J. L. Heerspink et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

V. Perkovic et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction

Yejin Mok et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Article Multidisciplinary Sciences

XX sex chromosome complement promotes atherosclerosis in mice

Yasir AlSiraj et al.

NATURE COMMUNICATIONS (2019)

Article Cardiac & Cardiovascular Systems

Microvascular Disease, Peripheral Artery Disease, and Amputation

Joshua A. Beckman et al.

CIRCULATION (2019)

Article Urology & Nephrology

Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis

Jason R. Stubbs et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Review Urology & Nephrology

Evolving concepts in the pathogenesis of uraemic cardiomyopathy

Xiaoliang Wang et al.

NATURE REVIEWS NEPHROLOGY (2019)

Article Urology & Nephrology

Estimated GFR: time for a critical appraisal

Esteban Porrini et al.

NATURE REVIEWS NEPHROLOGY (2019)

Article Urology & Nephrology

G1 is the major APOL1 risk allele for hypertension-attributed nephropathy in Central Africa

Ernest K. Sumaili et al.

CLINICAL KIDNEY JOURNAL (2019)

Article Urology & Nephrology

Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots

Petter Bjornstad et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2018)

Article Urology & Nephrology

Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease

Laetitia Dou et al.

KIDNEY INTERNATIONAL (2018)

Review Food Science & Technology

Gut Microbiota and Cardiovascular Uremic Toxicities

Manuel T. Velasquez et al.

TOXINS (2018)

Article Cardiac & Cardiovascular Systems

Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study

Junichi Ishigami et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

Article Cardiac & Cardiovascular Systems

Chronic kidney disease measures and the risk of abdominal aortic aneurysm

Kunihiro Matsushita et al.

ATHEROSCLEROSIS (2018)

Review Hematology

Venous thromboembolism, factor VIII and chronic kidney disease

Katharine L. Cheung et al.

THROMBOSIS RESEARCH (2018)

Article Cardiac & Cardiovascular Systems

Body Mass Index From Early-, Mid-, and Older-Adulthood and Risk of Heart Failure and Atherosclerotic Cardiovascular Disease: MESA

Michael Fliotsos et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

Article Urology & Nephrology

Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients

Tariq Shafi et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Review Endocrinology & Metabolism

Dyslipidemia in patients with chronic kidney disease

Matthew R. Hager et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2017)

Article Cardiac & Cardiovascular Systems

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease

Stephen Zewinger et al.

EUROPEAN HEART JOURNAL (2017)

Review Cardiac & Cardiovascular Systems

Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis

Gabriele Giacomo Schiattarella et al.

EUROPEAN HEART JOURNAL (2017)

Review Medicine, General & Internal

Kidney disease and venous thromboembolism: Does being woman make the difference?

A. Gigante et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)

Review Biochemistry & Molecular Biology

Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms

Jasdeep Kaur et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Urology & Nephrology

Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD

Markus P. Schneider et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Review Urology & Nephrology

The systemic nature of CKD

Carmine Zoccali et al.

NATURE REVIEWS NEPHROLOGY (2017)

Article Cardiac & Cardiovascular Systems

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study

Kunihiro Matsushita et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)

Article Urology & Nephrology

Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes

Sarah Gilligan et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2017)

Review Hematology

Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases

Arthur P. Arnold et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)

Article Medicine, General & Internal

Obesity and inflammation: the linking mechanism and the complications

Mohammed S. Ellulu et al.

ARCHIVES OF MEDICAL SCIENCE (2017)

Article Cardiac & Cardiovascular Systems

Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study

Takeki Suzuki et al.

AMERICAN HEART JOURNAL (2016)

Article Cardiac & Cardiovascular Systems

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Massimo F. Piepoli et al.

EUROPEAN HEART JOURNAL (2016)

Review Cardiac & Cardiovascular Systems

Low glomerular filtration rate and risk of myocardial infarction: A systematic review and meta-analysis

Vishal Vashistha et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Article Medicine, General & Internal

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure A Meta-analysis

Navdeep Tangri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Medicine, General & Internal

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Jackson T. Wright et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Cardiac & Cardiovascular Systems

Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants

Kaoru Ito et al.

CIRCULATION RESEARCH (2014)

Review Cardiac & Cardiovascular Systems

Medial vascular calcification revisited: review and perspectives

Peter Lanzer et al.

EUROPEAN HEART JOURNAL (2014)

Article Urology & Nephrology

Fibroblast Growth Factor-23 and Cardiovascular Events in CKD

Julia J. Scialla et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Article Urology & Nephrology

Longitudinal Changes of Cardiac Structure and Function in CKD (CASCADE Study)

Qi-Zhe Cai et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Review Urology & Nephrology

The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review

Raymond Vanholder et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Review Urology & Nephrology

Pathophysiology of Resistant Hypertension in Chronic Kidney Disease

Vito M. Campese

SEMINARS IN NEPHROLOGY (2014)

Review Medicine, General & Internal

Aldosterone antagonists for preventing the progression of chronic kidney disease

Davide Bolignano et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)

Article Hematology

Chronic Kidney Disease, Plasma Lipoproteins, and Coronary Artery Calcium Incidence The Multi-Ethnic Study of Atherosclerosis

Julio A. Lamprea-Montealegre et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)

Article Medicine, General & Internal

Chronic kidney disease: global dimension and perspectives

Vivekanand Jha et al.

LANCET (2013)

Review Urology & Nephrology

Mechanisms of vascular calcification in CKD-evidence for premature ageing?

Catherine M. Shanahan

NATURE REVIEWS NEPHROLOGY (2013)

Article Medicine, General & Internal

Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk

W. H. Wilson Tang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Cystatin C versus Creatinine in Determining Risk Based on Kidney Function

Michael G. Shlipak et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Medicine, General & Internal

Effect of lower sodium intake on health: systematic review and meta-analyses

Nancy J. Aburto et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Article Urology & Nephrology

Notice

Kidney International Supplements (2013)

Article Medicine, General & Internal

Age and Association of Kidney Measures With Mortality and End-stage Renal Disease

Stein I. Hallan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Urology & Nephrology

Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD

Meyeon Park et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)

Article Medicine, General & Internal

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

Stephen Kaptoge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

Lesley A. Inker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Urology & Nephrology

Notice

Kidney International Supplements (2012)

Article Medicine, General & Internal

A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure

Navdeep Tangri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Medicine, Research & Experimental

FGF23 induces left ventricular hypertrophy

Christian Faul et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Urology & Nephrology

FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis

Jessica Kendrick et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Editorial Material Urology & Nephrology

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

Andrew S. Levey et al.

KIDNEY INTERNATIONAL (2011)

Editorial Material Medicine, General & Internal

Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials

Feng J. He et al.

LANCET (2011)

Article Urology & Nephrology

Total and Individual Coronary Artery Calcium Scores as Independent Predictors of Mortality in Hemodialysis Patients

Ronney S. Shantouf et al.

AMERICAN JOURNAL OF NEPHROLOGY (2010)

Article Urology & Nephrology

p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease

Bjorn K. I. Meijers et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Editorial Material Medicine, General & Internal

Microvascular complications: pathophysiology and management

Karunakaran Vithian et al.

CLINICAL MEDICINE (2010)

Review Biochemistry & Molecular Biology

Oxidative Stress in Diabetic Nephropathy

N. Kashihara et al.

CURRENT MEDICINAL CHEMISTRY (2010)

Article Cardiac & Cardiovascular Systems

Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community

Ravi Dhingra et al.

EUROPEAN JOURNAL OF HEART FAILURE (2010)

Article Transplantation

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease

Sophie Liabeuf et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)

Article Transplantation

Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts

Farsad Afshinnia et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)

Article Medicine, General & Internal

Low glomerular filtration rate and risk of stroke: meta-analysis

Meng Lee et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Article Urology & Nephrology

The Uremic Retention Solute p-Cresyl Sulfate and Markers of Endothelial Damage

Bjorn K. I. Meijers et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2009)

Article Urology & Nephrology

Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease

Jill Melendez Young et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Urology & Nephrology

Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

Fellype C. Barreto et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Neurosciences

Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans

Colin N. Young et al.

JOURNAL OF PHYSIOLOGY-LONDON (2009)

Review Urology & Nephrology

Sympathetic Activation in Chronic Renal Failure

Markus P. Schlaich et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Review Urology & Nephrology

Measured GFR as a Confirmatory Test for Estimated GFR

Lesley A. Stevens et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Urology & Nephrology

Factors other than glomerular filtration rate affect serum cystatin C levels

Lesley A. Stevens et al.

KIDNEY INTERNATIONAL (2009)

Article Medicine, General & Internal

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies

Pasquale Strazzullo et al.

BMJ-BRITISH MEDICAL JOURNAL (2009)

Review Cardiac & Cardiovascular Systems

Cardiorenal Syndrome

Claudio Ronco et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Medicine, General & Internal

Effect of a multifactorial intervention on mortality in type 2 diabetes

Peter Gaede et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Medicine, General & Internal

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Orlando M. Gutierrez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Urology & Nephrology

Reduced kidney function as a risk factor for incident heart failure: The Atherosclerosis Risk in Communities (ARIC) study

Anna Kottgen et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Article Transplantation

Managing a fateful alliance: anaemia and cardiovascular outcomes

KU Eckardt

NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)

Article Urology & Nephrology

Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study

H Kramer et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)

Article Urology & Nephrology

Serum phosphate levels and mortality risk among people with chronic kidney disease

B Kestenbaum et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)

Article Medicine, General & Internal

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

P Gaede et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Urology & Nephrology

Sympathetic nerve activity is inappropriately increased in chronic renal disease

IHHT Klein et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)

Article Peripheral Vascular Disease

Norepinephrine and concentric hypertrophy in patients with end-stage renal disease

C Zoccali et al.

HYPERTENSION (2002)

Article Cardiac & Cardiovascular Systems

Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation

ML Hijmering et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)

Article Biochemistry & Molecular Biology

Severely reduced production of Klotho in human chronic renal failure kidney

N Koh et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)